TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26556074

Group type: EXPERIMENTAL
Intervention: Whole body vibration training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 24340770

Group type: EXPERIMENTAL
Intervention: Medication based on antlers of Siberian stags
Number of subjects: 0
Study: 21278140

Group type: EXPERIMENTAL
Intervention: NAFLD group
Number of subjects: 7849

Group type: COMPARATOR
Intervention: Non-NAFLD group
Number of subjects: 7849

Group type: EXPERIMENTAL
Intervention: Impaired fasting glucose group with NAFLD
Number of subjects: 7849
Study: 19833861

Group type: EXPERIMENTAL
Intervention: Laropiprant with extended-release niacin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Extended-release niacin alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Laropiprant alone
Number of subjects: 0
Study: 16380313

Group type: EXPERIMENTAL
Intervention: Contingent feedback
Number of subjects: 38

Group type: COMPARATOR
Intervention: Noncontingent feedback
Number of subjects: 38
Study: 15154607

Group type: EXPERIMENTAL
Intervention: 2.0 g daily GLA (borage oil)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Corn oil (placebo)
Number of subjects: 24
Study: 10631624

Group type: EXPERIMENTAL
Intervention: Doxazosin 2 mg tablet
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (healthy subjects)
Number of subjects: 24
Study: 9181630

Group type: EXPERIMENTAL
Intervention: Trazodone (50, 100 and 200 mg)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Triazolam (0.125, 0.25, 0.50 mg)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 1373007

Group type: EXPERIMENTAL
Intervention: Hypertonic saline solution (7.5% NaCl)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Hypertonic saline plus dextran (7.5% NaCl plus 6% dextran 70)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Isotonic saline solution
Number of subjects: 105
Study: 2857210

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 50 mg twice a day
Number of subjects: 14

Group type: COMPARATOR
Intervention: Propranolol 80 mg twice a day
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Combination of hydrochlorothiazide and propranolol
Number of subjects: 14
Study: 30893841

Group type: EXPERIMENTAL
Intervention: Curtailed night (CN)
Number of subjects: 24
Study: 28847038

Group type: EXPERIMENTAL
Intervention: Leicester PPH predict score
Number of subjects: 24230
Study: 28515369

Group type: EXPERIMENTAL
Intervention: Aggressive lipid- and blood pressure-lowering therapy
Number of subjects: 68
Study: 26713871

Group type: EXPERIMENTAL
Intervention: Facilitated local stakeholder groups for improved neonatal survival
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control area (no intervention)
Number of subjects: 0
Study: 24634929

Group type: EXPERIMENTAL
Intervention: Preoperative carbohydrate-rich beverage (fed group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nothing by mouth (fasting group)
Number of subjects: 0
Study: 22170452

Group type: EXPERIMENTAL
Intervention: Self-care workshops over the course of 2 months
Number of subjects: 74

Group type: COMPARATOR
Intervention: No intervention (Control group)
Number of subjects: 74
Study: 18319412

Group type: EXPERIMENTAL
Intervention: Gemcitabine (30-minute infusion of 1000 mg/m2 once per week for 3 weeks prior to chemoradiation and for 12 weeks after chemoradiation)
Number of subjects: 451

Group type: COMPARATOR
Intervention: Fluorouracil (continuous infusion of 250 mg/m2 per day for 3 weeks prior to chemoradiation and for 12 weeks after chemoradiation)
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Gemcitabine
Number of subjects: 451

Group type: COMPARATOR
Intervention: Fluorouracil
Number of subjects: 451
Study: 16870074

Group type: EXPERIMENTAL
Intervention: 12 μg/h fentanyl transdermal system (fentanyl TTS)
Number of subjects: 227
Study: 12673712

Group type: EXPERIMENTAL
Intervention: Etoposide, ifosfamide, and cisplatin (VIP)
Number of subjects: 286

Group type: COMPARATOR
Intervention: Bleomycin, etoposide, and cisplatin (BEP)
Number of subjects: 286
Study: 10897509

Group type: EXPERIMENTAL
Intervention: Community pharmacist-managed repeat prescribing system
Number of subjects: 3074

Group type: COMPARATOR
Intervention: Established methods of managing repeat prescribing
Number of subjects: 3074
Study: 9050128

Group type: EXPERIMENTAL
Intervention: Smoking (as an intervention)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Nonsmoking (as a control)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Neuroleptic doses
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 90
Study: 8416329

Group type: EXPERIMENTAL
Intervention: Early ambulation (group A) 6 hours after catheterization
Number of subjects: 273

Group type: COMPARATOR
Intervention: Late ambulation (group B) the following morning
Number of subjects: 273
Study: 3532010

Group type: EXPERIMENTAL
Intervention: Aerosolized metaproterenol
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Aerosolized metaproterenol (second treatment)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Subcutaneous epinephrine
Number of subjects: 35
Study: 29860500

Group type: EXPERIMENTAL
Intervention: Intralipid/heparin infusion
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 10
Study: 27381665

Group type: EXPERIMENTAL
Intervention: Transcatheter Aortic Valve Replacement (TAVR)
Number of subjects: 353

Group type: COMPARATOR
Intervention: Surgical Aortic Valve Replacement (SAVR)
Number of subjects: 353
Study: 23969265

Group type: EXPERIMENTAL
Intervention: 100 kVp protocol with 20% reduced contrast dose
Number of subjects: 100

Group type: COMPARATOR
Intervention: 120 kVp protocol (control group)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 100 kVp protocol
Number of subjects: 100
Study: 22107850

Group type: EXPERIMENTAL
Intervention: MenACWY‐TT and HepA/B (Twinrix) co-administered
Number of subjects: 611

Group type: COMPARATOR
Intervention: MenACWY‐TT alone
Number of subjects: 611

Group type: COMPARATOR
Intervention: HepA/B (Twinrix) alone
Number of subjects: 611
Study: 20831889

Group type: EXPERIMENTAL
Intervention: Oral-appliance therapy
Number of subjects: 103

Group type: COMPARATOR
Intervention: CPAP therapy
Number of subjects: 103
Study: 19087312

Group type: EXPERIMENTAL
Intervention: Water gargling
Number of subjects: 252

Group type: COMPARATOR
Intervention: Control
Number of subjects: 252
Study: 17121041

Group type: EXPERIMENTAL
Intervention: Yunpi Zhixie Granule (YZG)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Smacta (Control)
Number of subjects: 300
Study: 12834936

Group type: EXPERIMENTAL
Intervention: 100 mg pethidine
Number of subjects: 59

Group type: COMPARATOR
Intervention: 100 mg tramadol
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 59
Study: 10634681

Group type: EXPERIMENTAL
Intervention: Intensive prevention (counseling, F‐varnish applications, F‐lozenges, sealants, chlorhexidine)
Number of subjects: 1465

Group type: COMPARATOR
Intervention: Basic prevention (counseling, one F‐varnish application/year)
Number of subjects: 1465
Study: 7707278

Group type: EXPERIMENTAL
Intervention: Hyoscine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cinnarizine
Number of subjects: 0
Study: 2764852

Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg, t.i.d.)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (t.i.d.)
Number of subjects: 12
Study: 360903

Group type: COMPARATOR
Intervention: 5% ribavirin in ointment base
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Ribavirin
Number of subjects: 390
Study: 31424713

Group type: EXPERIMENTAL
Intervention: Halobetasol 0.01%/Tazarotene 0.045% lotion (HP/TAZ)
Number of subjects: 418

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 418
Study: 28151877

Group type: EXPERIMENTAL
Intervention: Standardized patients training
Number of subjects: 242

Group type: COMPARATOR
Intervention: Traditional small group seminars
Number of subjects: 242
Study: 25614945

Group type: EXPERIMENTAL
Intervention: Intrabeam device delivering 14 Gy to a 2-mm depth during surgery
Number of subjects: 23
Study: 23894178

Group type: EXPERIMENTAL
Intervention: Multifaceted educational intervention including two visits by peer academic detailers and regional seminars.
Number of subjects: 382

Group type: COMPARATOR
Intervention: Control intervention targeting prescribing practice for older patients.
Number of subjects: 382
Study: 20619489

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18199805

Group type: EXPERIMENTAL
Intervention: Sevelamer hydrochloride
Number of subjects: 119

Group type: COMPARATOR
Intervention: Calcium carbonate
Number of subjects: 119
Study: 16521770

Group type: EXPERIMENTAL
Intervention: Various numbers of equal log‐ or ERBN‐width subbands
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Partition bandwidth corresponding to asymptotic performance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Partition bandwidths at asymptote in low-frequency region
Number of subjects: 0
Study: 12760443

Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 594

Group type: COMPARATOR
Intervention: Other weight-reducing diets
Number of subjects: 594

Group type: EXPERIMENTAL
Intervention: Low-fat diet and other weight-reducing diets
Number of subjects: 594
Study: 11125309

Group type: EXPERIMENTAL
Intervention: Zidovudine treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Untreated HIV-1 infected pregnant women
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy women
Number of subjects: 0

Group type: COMPARATOR
Intervention: HIV-1 infected groups
Number of subjects: 0
Study: 9326127

Group type: EXPERIMENTAL
Intervention: Magnesium supplementation during and after cardiac surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cardiac surgery
Number of subjects: 0
Study: 8466427

Group type: EXPERIMENTAL
Intervention: Experimental group (E) - vinyl urinary bags reused for 4 weeks with daily decontamination using dilute bleach rinse
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (C) - vinyl urinary bags replaced weekly
Number of subjects: 54
Study: 3026052

Group type: EXPERIMENTAL
Intervention: Megestrol acetate (40 mg orally four times daily)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Tamoxifen (10 mg orally twice daily)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Megestrol acetate after crossover from tamoxifen
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Tamoxifen after crossover from megestrol acetate
Number of subjects: 190
Study: 30734195

Group type: EXPERIMENTAL
Intervention: Pyloric injection of magnesium sulfate-lidocaine mixture
Number of subjects: 70

Group type: COMPARATOR
Intervention: Pyloric injection of normal saline (control)
Number of subjects: 70
Study: 29316213

Group type: EXPERIMENTAL
Intervention: Valsartan/cilnidipine
Number of subjects: 129

Group type: COMPARATOR
Intervention: Valsartan/hydrochlorothiazide
Number of subjects: 129
Study: 27438870

Group type: EXPERIMENTAL
Intervention: Tinnitus Masking (TM)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Tinnitus Retraining Therapy (TRT)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Tinnitus Educational Counseling (TED)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Wait-list Control (WLC)
Number of subjects: 148
Study: 24695720

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (tDCS) applied to the right cerebellum
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cathodal transcranial direct current stimulation (tDCS) applied to the right cerebellum
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation (control)
Number of subjects: 0
Study: 22503163

Group type: EXPERIMENTAL
Intervention: Increase - Decrease group
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Increase group
Number of subjects: 88

Group type: COMPARATOR
Intervention: Minimum Intervention group
Number of subjects: 88
Study: 20113397

Group type: EXPERIMENTAL
Intervention: Vardenafil 10 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18806039

Group type: EXPERIMENTAL
Intervention: Ventilation with PEEP (10 cm H2O)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ventilation with zero end-expiratory pressure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increasing end-expiratory pressure in isolated perfused mouse lungs (IPL)
Number of subjects: 0
Study: 16202958

Group type: EXPERIMENTAL
Intervention: Bupropion sustained release (SR)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 11933664

Group type: EXPERIMENTAL
Intervention: Functional treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intermaxillary fixation
Number of subjects: 40
Study: 10075322

Group type: EXPERIMENTAL
Intervention: Partially defatted flaxseed (approximately 50 g partially defatted flaxseed/d)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Wheat bran (control)
Number of subjects: 29
Study: 8549576

Group type: EXPERIMENTAL
Intervention: Concentric contractions (CL)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Eccentric contractions (EL)
Number of subjects: 10
Study: 1898585

Group type: EXPERIMENTAL
Intervention: Mupirocin intranasally twice daily for 5 days
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 6648120

Group type: EXPERIMENTAL
Intervention: Dental health education
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dental delivery
Number of subjects: 0
Study: 31401909

Group type: EXPERIMENTAL
Intervention: Problem-solving therapy (PST-PC)
Number of subjects: 352
Study: 28279086

Group type: EXPERIMENTAL
Intervention: Financial incentives for weight loss (0, 1, 2, or 3 incentives awarded quarterly over 1 year)
Number of subjects: 544

Group type: EXPERIMENTAL
Intervention: Financial incentives for medication compliance (0, 1, 2, or 3 incentives awarded quarterly over 1 year)
Number of subjects: 544

Group type: EXPERIMENTAL
Intervention: Financial incentives for physical activity (0, 1, 2, or 3 incentives awarded quarterly over 1 year)
Number of subjects: 544

Group type: COMPARATOR
Intervention: Financial incentives (0, 1, 2, or 3 incentives awarded quarterly over 1 year)
Number of subjects: 544
Study: 26997192

Group type: EXPERIMENTAL
Intervention: Descriptive-norms-feedback-only condition
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Descriptive-plus-injunctive-message condition
Number of subjects: 176

Group type: COMPARATOR
Intervention: Assessment-only control condition
Number of subjects: 176
Study: 25191766

Group type: EXPERIMENTAL
Intervention: alpha-lipoic acid (LA) supplementation (500 mg/day) for three months
Number of subjects: 56
Study: 22027944

Group type: EXPERIMENTAL
Intervention: Red ginseng (3 g per day, including 60 mg of ginsenosides)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 20501928

Group type: EXPERIMENTAL
Intervention: Reports with spin in the title
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Reports with spin in the Results section
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Reports with spin in the Conclusions section
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Reports with spin focusing only on treatment effectiveness
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Reports with spin in the main-text Results section
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Reports with spin in the main-text Discussion section
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Reports with spin in the main-text Conclusions section
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Reports with spin in at least 2 sections of the main text
Number of subjects: 72
Study: 18520980

Group type: EXPERIMENTAL
Intervention: 200-mg retarded-release levodopa/carbidopa (LD/CD)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 150-mg levodopa/carbidopa/entacapone (LD/CD/EN)
Number of subjects: 12
Study: 16145047

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 5187

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5187
Study: 12105354

Group type: EXPERIMENTAL
Intervention: 3.5-MHz convex probe
Number of subjects: 20

Group type: COMPARATOR
Intervention: 7.5-MHz linear probe
Number of subjects: 20
Study: 10027435

Group type: EXPERIMENTAL
Intervention: Oxitropium
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Fenoterol
Number of subjects: 20
Study: 7538240

Group type: EXPERIMENTAL
Intervention: 15 W for 180 s
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 50 W for 60 s
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 15 W for 180 s and 50 W for 60 s (both groups)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 29
Study: 1828336

Group type: EXPERIMENTAL
Intervention: n-3 fatty acids (2.04 g/d)
Number of subjects: 33

Group type: COMPARATOR
Intervention: safflower oil (4.8 g/d of linoleic acid)
Number of subjects: 33
Study: 116282

Group type: EXPERIMENTAL
Intervention: Oxprenolol (480 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Lorazepam (2 mg)
Number of subjects: 6
Study: 30612727

Group type: EXPERIMENTAL
Intervention: Insulin-treated diabetes mellitus (ITDM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-insulin treated diabetes mellitus (NITDM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No diabetes (non-DM)
Number of subjects: 0
Study: 28601692

Group type: EXPERIMENTAL
Intervention: Family-centered affective stimulation
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo sensory stimulation
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control sensory stimulation
Number of subjects: 90
Study: 26547465

Group type: EXPERIMENTAL
Intervention: Endovascular revascularization plus supervised exercise
Number of subjects: 212

Group type: COMPARATOR
Intervention: Supervised exercise only
Number of subjects: 212
Study: 23982032

Group type: EXPERIMENTAL
Intervention: Enhanced protein-energy provision via the enteral route feeding protocol
Number of subjects: 1059

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1059
Study: 23256709

Group type: EXPERIMENTAL
Intervention: Hip osteoarthritis patients
Number of subjects: 48

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Hip osteoarthritis patients with minimal joint space ≤2 mm
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Hip osteoarthritis patients with minimal joint space >2 mm
Number of subjects: 48
Study: 21069109

Group type: EXPERIMENTAL
Intervention: Diode laser (LaserSmile) activation of 38% hydrogen peroxide
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ozone device (HealOzone) activation of 38% hydrogen peroxide
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Light-emitting diode (BT Cool whitening system) activation of 38% hydrogen peroxide
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Quartz-Plus activation of 38% hydrogen peroxide
Number of subjects: 50

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 50
Study: 17974868

Group type: EXPERIMENTAL
Intervention: Multicomponent behavioral treatment (MBT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sleep hygiene education (SHE)
Number of subjects: 20
Study: 15097303

Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Stavudine (d4T)
Number of subjects: 100
Study: 11666123

Group type: EXPERIMENTAL
Intervention: TTFCA (total triterpenic fraction of Centella asiatica), 60 mg twice daily for 6 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 9638433

Group type: EXPERIMENTAL
Intervention: alpha-interferon treatment
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 80
Study: 8053015

Group type: EXPERIMENTAL
Intervention: Intramuscular artemether
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intramuscular sulfadoxine‐pyrimethamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous quinine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall mortality
Number of subjects: 0
Study: 3384975

Group type: EXPERIMENTAL
Intervention: Kernberg's stimulus
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Kohut's stimulus
Number of subjects: 70

Group type: COMPARATOR
Intervention: Neutral content stimulus (Control)
Number of subjects: 70
Study: 29550012

Group type: EXPERIMENTAL
Intervention: WaveOne Gold Glider
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: PathFile
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: K-file
Number of subjects: 60

Group type: COMPARATOR
Intervention: No glide path preparation
Number of subjects: 60
Study: 26899011

Group type: EXPERIMENTAL
Intervention: Adhflex
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sutures
Number of subjects: 60
Study: 24646034

Group type: EXPERIMENTAL
Intervention: Aerosolized antibiotics (AA) given for 14 days or until extubation.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Saline placebo given for 14 days or until extubation.
Number of subjects: 50
Study: 23970790

Group type: EXPERIMENTAL
Intervention: Suprascapular nerve block (SSNB)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 64
Study: 19942463

Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation (SCS)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Brush-evoked allodynia
Number of subjects: 36
Study: 18043966

Group type: EXPERIMENTAL
Intervention: Artificial Neural Networks (ANNs)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Clinical assessment by experienced clinicians
Number of subjects: 60

Group type: COMPARATOR
Intervention: Alvarado score (score >= 6)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Alvarado score (score >= 7)
Number of subjects: 60
Study: 16027801

Group type: EXPERIMENTAL
Intervention: Probucol 250 mg/day for 7-10 days before and 6 months after angioplasty
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Probucol 250 mg/day for 6 months after angioplasty
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no probucol therapy)
Number of subjects: 0
Study: 12824826

Group type: EXPERIMENTAL
Intervention: Laser photocoagulation therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 0
Study: 10224951

Group type: EXPERIMENTAL
Intervention: Short delay conditioning (CS presented for 15 seconds followed by US for 30 seconds)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Backward conditioning
Number of subjects: 9

Group type: COMPARATOR
Intervention: Random control condition
Number of subjects: 9
Study: 8637110

Group type: EXPERIMENTAL
Intervention: Surgical intervention (CEA)
Number of subjects: 825

Group type: COMPARATOR
Intervention: Medical management
Number of subjects: 825